Telavancin Observational Use Registry (TOUR)

Trial Profile

Telavancin Observational Use Registry (TOUR)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Telavancin (Primary)
  • Indications Bacteraemia; Bone and joint infections; Endocarditis; Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Acronyms TOUR
  • Sponsors Theravance Biopharma
  • Most Recent Events

    • 09 Oct 2017 According to a Theravance Biopharma media release, preliminary data from the study has been presented at IDWeek™ 2017.
    • 09 Oct 2017 According to a Theravance Biopharma media release, the company plans to present additional collections of data from the study at appropriate upcoming scientific conferences.
    • 09 Oct 2017 Results presented in a Theravance Biopharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top